Efrat Shema's Lab

Decoding the Cancer Epigenome

Selected Publications

Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneity

Furth N., Cohen N., Spitzer A. et al. (2025) Proceedings of the National Academy of Sciences - PNAS. 122, 1, e240386212.

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Isshiki Y., Chen X., Teater M. et al. (2024) Cancer Cell. 43, 1, p. 49-68.e9

ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response

Lim L. Q. J., Adler L., Hajaj E. et al. (2024) Nature metabolism. 6, 7, p. 1294-1309
All Publications